Pharmaceutical business slowdown forecast to deepen next year

Published: 2002-11-21 06:59:00

Updated: 2002-11-21 06:59:00

The pharmaceutical business slowdown is expected to further accelerate next year, as the profitability of listed pharmaceutical firms are rapidly aggravated since latter half of this year due to the sluggish growth.

Business sources say that the current downturn trend of pharmaceutical busine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK